Karin Ann Thacker
Conseiller Juridique Général chez SENTI BIOSCIENCES, INC.
Profil
Karin Ann Thacker is currently the Vice President-Quality & Regulatory Affairs at Senti Biosciences, Inc. She previously worked as the Senior Director & Head-Regulatory Development at Puma Biotechnology, Inc. from 2015 to 2016.
From 2020 to 2022, she served as the VP-Regulatory Affairs & Quality Assurance at Harpoon Therapeutics, Inc. Prior to that, she was the Vice President-Global Regulatory Affairs at Gritstone bio, Inc. from 2016 to 2020.
Ms. Thacker completed her undergraduate and graduate degrees at the University of Manitoba.
Postes actifs de Karin Ann Thacker
Sociétés | Poste | Début |
---|---|---|
SENTI BIOSCIENCES, INC. | Conseiller Juridique Général | - |
Anciens postes connus de Karin Ann Thacker
Sociétés | Poste | Fin |
---|---|---|
HARPOON THERAPEUTICS, INC. | Conseiller Juridique Général | 01/08/2022 |
GRITSTONE BIO, INC. | Conseiller Juridique Général | 01/08/2020 |
PUMA BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 01/05/2016 |
Formation de Karin Ann Thacker
University of Manitoba | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
GRITSTONE BIO, INC. | Health Technology |
PUMA BIOTECHNOLOGY, INC. | Health Technology |
SENTI BIOSCIENCES, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Harpoon Therapeutics, Inc.
Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. The firm utilizes its proprietary Tri-specific T cell Activating Construct platform to create a pipeline of novel TriTACs for the treatment of solid tumors and hematologic malignancies. The company was founded by Patrick A. Baeuerle, Luke B. Evnin, and Jeanmarie Guenot on March 19, 2015 and is headquartered in South San Francisco, CA. | Health Technology |